Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4
Qing Luo(Jiangnan University), Yongxiang Yin
Cited by 4
Related Papers
Increased TIGIT<sup>+</sup>PD‑1<sup>+</sup>CXCR5<sup>‑</sup>CD4<sup>+</sup>T cells are associated with disease activity in rheumatoid arthritis
|Experimental and Therapeutic Medicine|2022|7